Dorothy J. Clarke
General CounselMs. Dorothy J. Clarke was a Director at Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) since August 28, 2023 until January 6, 2025. She served as Director of Comera Life Sciences Holdings, Inc. since November 2023 until February 2024. She has been General Counsel at Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) since January 01, 2024. She served in various roles with Johnson & Johnson (?J&J?) from April 2002 until November 2022, with the most recent position being Vice President, Health Care Compliance, Research & Development, Innovation and Business Development. Before that, Ms. Clarke served as Vice President, Health Care Compliance for the Medical Devices segment of J&J and Chief Privacy Officer of J&J. From January 2016 until December 2021, Ms. Clark served on the board of trustees of the Reformed Church of Highland Park Affordable Housing Corporation. Ms. Clark received her B.A in history from Wesleyan University and her Juris Doctorate from New York University School of Law.
Positions
- Company NameErnexa Therapeutics Inc.Stock CodeERNAPositionGeneral CounselRelated SecuritiesColleagues
- SLSanjeev LutherCEO, President & Director
- JAJames A. BristolIndependent Chairman of the Board
- MJMark J. KeeleyChief Financial Officer
- DVDeborah Vee WildHead of CMC & Operations
- RHRobert Hamilton PierceChief Scientific Officer
- WAWilliam A. WexlerIndependent Director
- CRChristopher RohdeMember of Scientific Advisory Board
- MAMichael AndreeffMember of Scientific Advisory Board
